The Efficacy of Hemoglobin, Albumin, Lymphocytes, and Platelets as a Prognostic Marker for Survival in Octogenarians and Nonagenarians Undergoing Colorectal Cancer Surgery
Cancer Biotherapy and Radiopharmaceuticals · 2022-12 · 37 (10) · 955-962
DOI: 10.1089/cbr.2020.4725 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, online erschienen am 12.12.2022. Verfasst von Hasan Dagmura und 2 weiteren Autor:innen. Beteiligte Einrichtung: General Surgery and Surgical Oncology Department, Kütahya Health Sciences University Evliya Çelebi Training and Research Hospital, Kütahya, Turkey. Hauptthemen laut MEDLINE: Octogenarians, Colorectal Neoplasms. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Abstract (Originalsprache)
Objectives
With the aging population worldwide, the octogenarians are becoming a substantial group and since cancer incidence increases by age, this group of patients is becoming more affected. However, no distinct treatment algorithm has been established for elderly patients with cancer. The present study aimed to determine the prognostic value of several inflammatory parameters by comparing octogenarian patients treated surgically for colorectal cancer with their younger counterparts, as well as to predict and prevent age-related complications in this frail group of patients.
Methods
The demographic and clinical data were collected from octogenarians and older people as case group (51 patients) and from a nonelderly control group of patients 65 years old or younger (88 patients).
Results
The results showed that Hemoglobin, Albumin, Lymphocytes, and Platelets (HALP) values were statistically different between case and control groups. Based on the results of the receiver operating characteristic analysis performed, there was a positive correlation between HALP and survival. HALP had a significant discrimination power at the good level [AUC = 0.775 (0.696-0.854); p < 0.001]. The multivariate model showed that age groups and HALP scores were significant factors for patient survival.
Conclusions
HALP biomarker was associated with the prognosis of patients treated surgically for colorectal cancer with curative intent. Furthermore, HALP score was significantly different in octogenarians compared to their younger counterparts. The newly formulated Hemoglobin, Albumin, Lymphocytes, Platelets, and Age (HALPA) appeared to be a promising biomarker of survival for elderly patients scheduled for colorectal cancer surgery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- General Surgery and Surgical Oncology Department, Kütahya Health Sciences University Evliya Çelebi Training and Research Hospital, Kütahya, Turkey.
- Department of General Surgery, Gaziosmanpasa University, Tokat, Turkey.
- Department of General Surgery and Surgical Oncology, Faculty of Medicine, Gaziosmanpasa University, Tokat, Turkey.
ORCID-Profile: Hasan Dagmura
Zitieren
APA
Dagmura, H., Daldal, E., & Okan, I. (2022). The Efficacy of Hemoglobin, Albumin, Lymphocytes, and Platelets as a Prognostic Marker for Survival in Octogenarians and Nonagenarians Undergoing Colorectal Cancer Surgery. Cancer Biotherapy and Radiopharmaceuticals, 37(10), 955-962. https://doi.org/10.1089/cbr.2020.4725
Vancouver
Dagmura H, Daldal E, Okan I. The Efficacy of Hemoglobin, Albumin, Lymphocytes, and Platelets as a Prognostic Marker for Survival in Octogenarians and Nonagenarians Undergoing Colorectal Cancer Surgery. Cancer Biotherapy and Radiopharmaceuticals. 2022;37(10):955-962. doi:10.1089/cbr.2020.4725
BibTeX
@article{Dagmura2022,
author = {Dagmura, Hasan and Daldal, Emin and Okan, Ismail},
title = {The Efficacy of Hemoglobin, Albumin, Lymphocytes, and Platelets as a Prognostic Marker for Survival in Octogenarians and Nonagenarians Undergoing Colorectal Cancer Surgery},
journal = {Cancer Biotherapy and Radiopharmaceuticals},
year = {2022},
volume = {37},
number = {10},
pages = {955--962},
doi = {10.1089/cbr.2020.4725}
}
EUVIMED